About
Technology
Issues
FAQ
Links
Official Page
Cost-Effectiveness of Ipilimumab Plus Anti-PD-1 Therapy Versus Ipilimumab Alone in Patients With Metastatic Melanoma Resistant to Anti-PD-(L)1 Monotherapy
site/software ©
exaly
; All materials licenced under
CC by-SA
.